In the rapidly evolving world of weight loss treatments, GLP-1 medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) have generated significant buzz
This once-weekly subcutaneous injection is not intended for long-term use at 0.25mg, but rather to help the body acclimate to semaglutide, minimizing gastrointestinal side effects before moving to higher therapeutic doses
This gel slows gastric emptying and moderates post-meal glucose spikes, supporting steadier energy and fewer cravings
Clinical trials show cholelithiasis occurs in approximately 2.5% of tirzepatide-treated patients versus 1.0% on placebo
Many users inject Retatrutide and their testosterone/Masteron/Primobolan on the same day or days
Clinically, bilateral lesions are seen on the buccal mucosa, but also on the lateral border of the tongue and even on the lips